What is the recommended dosage and application schedule for mupirocin ointment for skin infections and nasal MRSA decolonization in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mupirocin Ointment Dosage

For skin infections, apply mupirocin 2% ointment three times daily to the affected area for 5-10 days; for nasal MRSA decolonization, apply approximately 0.5 grams into each nostril twice daily for 5 days. 1

Skin Infections (Topical Application)

Application Schedule:

  • Apply a small amount of mupirocin 2% ointment to the affected area three times daily
  • Duration: 5-10 days (typically up to 10 days maximum) 1, 2
  • Use a cotton swab or gauze pad for application
  • May cover with gauze dressing if desired 1, 2

Clinical Context: The IDSA guidelines specifically recommend mupirocin 2% topical ointment for children with minor skin infections such as impetigo and secondarily infected skin lesions (eczema, ulcers, lacerations) 3. While the guidelines emphasize pediatric use, the FDA-approved dosing applies to both adults and children.

Important Caveat: Re-evaluate patients who show no clinical response within 3-5 days 1. If no improvement occurs in this timeframe, consider alternative diagnoses or systemic antibiotic therapy, particularly if there are signs of deeper infection or systemic illness.

Nasal MRSA Decolonization

Application Schedule:

  • Apply approximately 0.5 grams into each nostril
  • Twice daily for 5 consecutive days (total of 10 doses) 4
  • This is the FDA-approved regimen for eradicating nasal MRSA colonization

Evidence Supporting 10-Dose Regimen: Research demonstrates that the full 10-dose regimen (twice daily for 5 days) is superior to abbreviated 6-dose regimens. The 10-dose protocol achieved 89.5% sustained decolonization for at least 4 weeks post-treatment, compared to only 68.0% with 6-dose regimens 5. This difference is statistically significant and clinically meaningful for preventing recurrent infections.

Context for Recurrent MRSA Infections: For patients with recurrent S. aureus abscesses, the 2014 IDSA guidelines suggest considering a 5-day decolonization regimen that includes intranasal mupirocin twice daily, combined with daily chlorhexidine washes and decontamination of personal items 6.

Critical Restrictions and Warnings

Do NOT use mupirocin for:

  • Intranasal application of the topical skin formulation (different formulation exists for nasal use)
  • Ophthalmic use
  • Other mucosal surfaces 1

Avoid concurrent application with other lotions, creams, or ointments on the same area 1

Practical Algorithm for Choosing Duration

For skin infections:

  • Mild impetigo or small infected wounds: 5-7 days
  • More extensive infections or slow response: extend to 10 days
  • No improvement by day 3-5: stop mupirocin and reassess; consider systemic antibiotics if signs of deeper infection, cellulitis, or systemic illness 3

For nasal decolonization:

  • Always use the full 5-day course (10 doses) to maximize eradication and minimize resistance development 5
  • Do not use abbreviated regimens despite older literature suggesting shorter courses may work 7—the higher quality 2013 study definitively shows inferior outcomes 5

Resistance Considerations

While mupirocin remains effective for MRSA decolonization, resistance rates vary geographically (ranging from approximately 10% in some regions) 8. The judicious use of the full recommended course, rather than abbreviated regimens, helps preserve mupirocin's clinical utility and reduces selection pressure for resistance 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.